SLC6A4 and irritable bowel syndrome: Studies have revealed variable results regarding levels of 5‐HT and its metabolites in IBS,15, 22, 23, 24, 25 but SERT expression was consistently found reduced in GI tissues of IBS patients, which supports findings of increased 5‐HT in the tissue or blood.22, 23